Comparison of Hypercholesterolemic Men and Women at High Risk for Atherosclerosis. Study of Risk Factors and Response to PravastatinTreatment;Comparação entre Homens e Mulheres Hipercolesterolêmicos de Alto Risco de Desenvolvimento de Aterosclerose. Estudo dos Fatores de Risco e da Resposta ao Tratamento com Pravastatina

Arquivos Brasileiros de Cardiologia

Volumn 70, Issue 6, 1998, Pages 383-387

  Santos, Raul D ^a   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Hypercholesterolemia; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; FEMALE; GENDER; HEADACHE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRURITUS; RASH; SEXUAL DYSFUNCTION; SITTING; SMOKING; VOMITING; ARTERIOSCLEROSIS; BLOOD; BLOOD PRESSURE; BODY WEIGHT; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; MIDDLE AGED; PATIENT SELECTION; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; BLOOD PRESSURE; BODY WEIGHT; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PATIENT SELECTION; PRAVASTATIN; RISK FACTORS; SEX FACTORS;

EID: 0032086201     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x1998000600001     Document Type: Review

References (26)

1. Lotufo PA - A mortalidade precoce por doenças crônicas nas capitais deregiōes metiopolitanas brasileiras.[Tese de Doutorado] São Paulo, Faculdade de Saúde Pública da Universidade de São Paulo, 1996
2. Lotufo PA - Doenças cardiovasculares no Biasil. por que allas taxas de mortalidade entre mulheres ? Rev Soc Cardiol Estado de São Paulo 1996; 6: 667-71
3. Lessa I, Bastos CA - Epidemiology of cerebrovascular accidents in the city of Salvadoi, Bahia, Brazil. PAHO Bulletin 1986; 17: 292-303
4. Anderson KM, Wilson PWK, Odell PM, Kannel WB - An updated coronary risk profile, Circulation 1991; 83 356-62
5. Castelli WP, Garrison RJ, Wilson PWF, Abbot RD, Kalousdian S, Kannel WN -Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framinghum Heart Study. JAMA 1986; 256 2835-8
6. Friedwald WT, Levy RI, Fiedrickison DS - Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge Clin Chem 1972; 18 499-552.
7. Manson JE, Colditz GA, Stampfer MJ et al - A prospective study of maturity-onset diabetes mellitus and risk of coronbary heart disease and stroke in women. Arch Intern Med 1991; 265: 627-31
8. Wenger NK - Epidemiology of coronary heart disease in women. Rev Soc Cardiol Estado de São Paulo 1996; 6: 672-80
9. Welin L, Svardsudd K, Wilhelmsem L, Larson B, Tibblin G - Analysis of risk factors for stroke in a cohort of men born in 1913 N Eng J Med 1987; 317 521-6.
10. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH - Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension Ann Intern Med 1991; 114: 345-52.
11. Manson JE, Colditz GA, Stampfer MJ et al - A prospective study of obesity and risk of coronary heart disease in women N Eng J Med 1990; 322: 882-9.
12. Lobo RA - Effects of hormone i eplacement on lipids and lipoproteins in menopausal women. J Clin Endocrinol Metab 1991; 73 373-9.
13. Wilson PWF, Christiansen JC, Anderson KM et al - Impact of national guidelines for cholesterol risk factor screening The Framingham offspring study. JAMA 1989; 262; 41-4
14. Kannel WB - Range of serum cholesterol values in the population developing coronary artery disease Am J Cardiol 1995; 76 69C-77C.
15. Prihoda JS, Illingworth DR - Drag therapy of hyperlipidemia Curr Prob Cardiol 1992; 17 549-605.
16. 2○ Consenso Brasileiro de Dislipidemias. Arq Bras Cardiol 1996; 67: 109-28.
17. Shepherd J, Cobbe S M, Ford I et al - Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Eng J Med 1995; 333 1301-7.
18. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering 4,444 patients with coronary artery disease: Scandinavian Simvastatin Survival Study. Lancet 1994; 344; 1383-9.
19. Sacks FM, Pfeffer MA, Moye LA et al - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Eng J Med 1996; 335: 1001-9
20. Tonkin A - Long Term Intervention With Pravastatin in Ischemic Disease-LIPID Study. Apresentado no Congresso da American Heart Association, 1997.
21. Shepherd J, for the West of Scotland Prevention Study Economic Analysis Group The Cost effectiveness of preventing initial coronary events with pravastatin Results of the West of Scotland Coronary Prevention Study economic analysis. J Amer Coll Cardiol 1997; 29 suppl A: 168A.
22. Ashraf T, Hay JW, Pitt B et al - Cost effectiveness of pravastatin in secondary prevention of coronary artery disease. Am J Cardiol 1996; 78: 409-14.
23. Gray J - Clinical evidence for postmenopausal hormone replacement therapy Rev Soc Cardiol Estado de São Paulo 1996; 6: 718-23.
24. Feinberg WM, Albers GW, Barnett JM et al - Guidelines for the management of transient ischemic attacks Stroke 1994; 25: 1320-35
25. Herbert PR, Graziano JM, Chan KS, Hennekens CH - Cholesterol lowering with statin drugs, risk of stroke, and total mortality an overview of randomized trials. JAMA 1997; 278: 313-21.
26. Miettinen TA, Pyorala K, Olsson AO et al - Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study. Circulation 1997; 96: 4211-8.